Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009;10(4):1336-42.
doi: 10.1208/s12249-009-9335-x. Epub 2009 Nov 10.

Preparation and evaluation of thermosensitive liposomal hydrogel for enhanced transcorneal permeation of ofloxacin

Affiliations

Preparation and evaluation of thermosensitive liposomal hydrogel for enhanced transcorneal permeation of ofloxacin

Khaled Mohamed Hosny. AAPS PharmSciTech. 2009.

Abstract

Ofloxacin, available as ophthalmic solution, has two major problems: first, it needs frequent administration every 4 hours or even every 1 hour to treat severe eye infection; second, there is formation of white crystalline deposit on cornea due to its pH-dependent solubility, which is very low at pH of corneal fluid. In order to provide a solution to previous problems, ofloxacin in this study is prepared as topically effective in situ thermosensitive prolonged release liposomal hydrogel. Two preparation procedures were carried out, leading to the formation of multilamellar vesicles (MLVs) and reverse-phase evaporation vesicles (REVs) at pH 7.4. Effects of method of preparation, lipid content, and charge inducers on encapsulation efficiency were studied. For the preparation of in situ thermosensitive hydrogel, chitosan/beta-glycerophosphate system was synthesized and used as carrier for ofloxacin liposomes. The effect of addition of liposomes on gelation temperature, gelation time, and rheological behaviors of the hydrogel were evaluated. In vitro transcorneal permeation was also determined. MLVs entrapped greater amount of ofloxacin than REVs liposomes at pH 7.4; drug loading was increased by including charge-inducing agent and by increasing cholesterol content until a certain limit. The gelation time was decreased by the addition of liposomes into the hydrogel. The prepared liposomal hydrogel enhances the transcorneal permeation sevenfold more than the aqueous solution. These results suggested that the in situ thermosensitive ofloxacin liposomal hydrogel ensures steady and prolonged transcorneal permeation, which improves the ocular bioavailability, minimizes the need for frequent administration, and decreases the ocular side effect of ofloxacin.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Elastic modulus as a function of time at 37 ± 0.1°C for plain chitosan/β-GP solution and chitosan/β-GP solution containing ofloxacin liposomes. The frequency of oscillation is 1.0 Hz, and the acquisition rate is 1 point every 13 s
Fig. 2
Fig. 2
Transcorneal permeation profile of ofloxacin from liposomal hydrogel and liposomal suspension in comparison to its solution (mean ± SD, n = 3)

Similar articles

Cited by

References

    1. Budai L, Hajdu M, Budai M, Grof P, Beni S, Noszal B, Antal I, et al. Gels and liposomes in optimized ocular drug delivery: studies on ciprofloxacin formulations. Int J Pharm. 2007;343:34–40. doi: 10.1016/j.ijpharm.2007.04.013. - DOI - PubMed
    1. Kaur IP, kanwar M. Ocular preparations: the formulation approach. Drug Devel Ind Pharm. 2002;28:473–93. doi: 10.1081/DDC-120003445. - DOI - PubMed
    1. VanSantvliet L, Ludwig A. The influence of penetration enhancers on the volume instilled of eye drops. Eur J Pharm Biopharm. 1998;45:189–98. doi: 10.1016/S0939-6411(97)00114-8. - DOI - PubMed
    1. Alia AB, Hanan M, Riad K, Hala M, Mohamed D. Chitosan based nanocarriers for indomethacin ocular delivery. Arch Pharm Res. 2008;31(8):1040–9. doi: 10.1007/s12272-001-1266-6. - DOI - PubMed
    1. Adenis JP, Colin J, Verin P, Saint-Blancat P, Malet F. Ciprofloxacin ophthalmic solution versus rifamycin ophthalmic solution for the treatment of conjunctivitis and blepharitis. Eur J Ophthalmol. 1995;5:82–7. - PubMed